Stock data
60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals, Inc. (SXTP) reported revenue of US$1.01M and net income of -US$7.37M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.01M | US$0.22M | -US$7.76M | -US$7.37M | — |
| 2024 | US$0.61M | US$0.22M | -US$9.72M | -US$7.95M | — |
| 2023 | US$0.25M | -US$0.22M | -US$5.15M | -US$3.77M | — |
| 2022 | US$0.22M | -US$0.21M | -US$1.75M | -US$6.18M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.21M | -US$2.26M | — |
| 2026-03-31 | US$0.16M | -US$2.09M | — |
| 2025-12-31 | US$0.30M | -US$1.44M | — |
| 2025-09-30 | US$0.44M | -US$2.32M | — |
| 2025-06-30 | US$0.10M | -US$1.73M | — |
| 2025-03-31 | US$0.16M | -US$1.88M | — |
| 2024-12-31 | US$0.24M | -US$2.05M | — |
| 2024-09-30 | US$0.14M | -US$2.16M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.